U.S. Food and Drug Administration
Nutrasource Joins NASC as Preferred Supplier
Nutrasource Pharmaceutical and Nutraceutical Services (Guelph, ON, Canada), a global full-service contract research organization (CRO), has announced its membership into the NASC (National Animal Supplement Council) as a Preferred Supplier. Preferred Suppliers are companies that are pre-qualified to supply products and services to NASC Primary Suppliers without additional vendor qualifications that fall under NASC cGMPS ...
NJ Labs Celebrates 85 Years in the Testing Industry
While Dr. David Levowitz was at Rutgers University, he saw a growing need to promote quality in dairy and food production, so he created New Jersey Dairy Laboratories in 1936 for that purpose. At that time, he likely had no idea how comprehensive his laboratory would become. As NJ Labs (New Brunswick, NJ) celebrates its 85th year ...
CHPA Will Feature FDA Leadership, Industry Experts During Virtual Regulatory Conference
The Consumer Healthcare Products Association (CHPA) will hold its 2021 Regulatory, Scientific & Quality (RSQ) Conference virtually Sept. 9-10. CHPA said its annual event brings together an array of highly respected experts to discuss timely regulatory, scientific, legal, and product quality topics affecting the consumer health care products industry. After a year of unprecedented change in health ...
NPA Files Citizen Petition with FDA
In a Citizen’s Petition to the U.S. Food and Drug Administration (NPA), the Natural Products Association (NPA) requested that N-acetyl-L-cysteine (“NAC”) not be excluded from the definition of a dietary supplement. “The Food and Drug Administration has not established a public health risk for NAC,” said Daniel Fabricant, PhD, president and CEO of NPA. “Not ...
Associations Denounce FDA Rejection of NDI Notifications for Hemp Extract Containing CBD
The Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA) have denounced the U.S. Food and Drug Administration’s (FDA) rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract containing cannabidiol (CBD)—and urged Congress to act on pending legislative proposals that require the agency to address the lack of regulation of hemp-derived ...
CV Sciences and UC San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence
CV Sciences, Inc. (San Diego, CA) has announced progress toward its goal of developing and commercializing a CBD-based pharmaceutical to treat nicotine addiction in smokeless tobacco users. The company, in collaboration with researchers from the University of California, San Diego (UC San Diego), published a preclinical study demonstrating the efficacy of chronic CBD treatment in ...
AHPA Updates Guidance on Major Food Allergens in Response to FASTER Act
The American Herbal Products Association (AHPA) has published a revised version of the guidance document titled “Compliance with the Food Allergen Labeling and Consumer Protection Act (FALCPA) for Marketers of Chinese Herbal Products” to include the requirements of the recently adopted Food Allergy Safety, Treatment, Education and Research Act of 2021 (FASTER Act), which adds sesame to ...
New Draft Legislation Sets Safe Level of Consumption for CBD Products
New draft legislation includes a provision directing the U.S. Food and Drug Administration (FDA) to set a safe level of consumption for CBD products. The provision is part of a broader bill introduced by Senator Chuck Schumer (D-NY) that would decriminalize cannabis at the federal level. “Setting a safe level of consumption for CBD products ...
Nutrasource Receives U.S. Patent for GMO Testing Method
Nutrasource Pharmaceutical and Nutraceutical Services (Canada) has announced the reception of a USTPO (United States Patent and Trademark Office) on “Methods for detecting genetically modified organisms” for the IGEN certification program. The International Genetically Modified Organism (GMO) Evaluation and Notification program verifies label claims about the presence of GMOs in products and ingredients. Today, regulations ...
FDA Is Not Looking to “Throw Out DSHEA,” Says ODSP’s Welch
By Janet Poveromo During the American Herbal Products Association’s (AHPA) 9th Botanical Congress held virtually on May 24, Cara Welch, acting director of the Office of Dietary Supplements Programs (ODSP), U.S. Food and Drug Administration (FDA), told industry members that the FDA is not “looking to throw out DSHEA (Dietary Supplement Health and Education Act of ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
